Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $4.1200 (-0.12%) ($4.1200 - $4.1200) on Thu. Jan. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 22 | Latest Price | $4.1200(-0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2.1% a day on average for past five trading days. | Weekly Trend | AUTL declines -9.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(64%) IBB(60%) IBUY(57%) ARKG(53%) ARKK(53%) | Factors Impacting AUTL price | AUTL will decline at least -2.54% in a week (0% probabilities). VIXM(-42%) VXX(-34%) TLT(-23%) TIP(-22%) SHY(-22%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-12.11(-393.93%) | Resistance Level | $4.84 | 5 Day Moving Average | $4.25(-3.06%) | 10 Day Moving Average | $4.46(-7.62%) | 20 Day Moving Average | $4.84(-14.88%) | To recent high | -41.5% | To recent low | 0% | Market Cap | $215m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |